This website uses cookies to ensure you get the best experience on our website.
Read more
World Precision Instruments
Improving the Development
of Every Drug
of Every Drug
We strive to offer innovative solutions that empower the scientific community to discover
therapies that improve
patient care.
Key Facts
Founded in
1967
Over
100
Employees
Serving
20+
countries
We are investing in technologies to support and advance cell and gene therapies in an
effort to support therapeutic companies that develop novel therapies to improve patient outcomes.
Our Core Values
We strive to offer innovative solutions that empower the scientific community to discover therapies that improve patient care. The path to bringing novel therapies to patients across a multitude of disease areas begins with life science research and it begins with WPI.
Innovation
Precision
Excellence
Our Global Reach
World Precision Instruments has an extensive global network, operates in all major regions, and provides a global network of distribution partners. With four offices and distributors around the globe, WPI works with scientists in research labs in pharmaceutical companies and universities to design and manufacture solutions that push the boundaries of discovery and improve the lives of modern people.
Areas of Focus
Our vision is to improve the development of every drug by offering innovative solutions that empower the scientific community to discover therapies that improve patient care.
Basic
Research
Research
WPI supports both in vitro and in vivo model development to perform basic research in understanding physiological systems and identifying complex biology and pathologies associated with human health and disease.
Early Drug Discovery
Our instrumentation is developed to meet the needs of early drug discovery, including the ability to do high-throughput screening, automation of assays and micro-physiological systems, and standardization of cell sensing technologies like transepithelial electrical resistance (TEER) measurements.
Preclinical Drug Development
Our technology supports complex model development, including animal models and organ-on-a-chip systems, providing researchers with the tools to identify and validate drugs preclinically to understand mechanism of action, dosage, administration, drug-drug interactions, patient-specific reactions, pharmacokinetics, pharmacodynamics, safety and efficacy.
Clinical Development
We support the development of preclinical models for identification and validation of prognostic and diagnostic biomarkers.